Table 1.
Effect/ function/ action/ characteristic
|
E1
|
AE1
|
E2
|
AE2
|
Bind the ERs at the hormone binding site | ↑↑2 | X | ↑↑2 | ~ |
Bind the AF1 or AF2 sites of the ERs | X2 | ↑ | X2 | ~ |
Bind to mitochondria (and some membranes) | ~ | ~ | ↑2 | ↑2 |
Elicit a direct classic estrogenic response | ↑2 | X | ↑↑2 | ↑↑2 |
Induces hypoglycemic effects | ~i | ↑↑2 | ↑2 | ~ |
Is carried by lipoproteins | ↑2 | ↑↑2 | X | ↑2 |
Show anti-oxidative effects | ~ | ~ | ↑2 | ↑↑2 |
Activate the 3C→2C conversion (pyruvate dehydrogenase) | ~ | ↑2 | ↑↑2 | ~ |
Increase mitochondrial oxidative activity | ~ | ~ | ↑ | ~ |
Increase whole body thermogenesis | ~ | ↑2 | ↑2 | ~ |
Show lipolytic effects | X | ↑ | ↔ | ~ |
Show lipogenic effects | ↑ | ↓2 | ↓2 | ~ |
Decrease WAT fat mass/ limits fat deposition | ↓ | ↑↑2 | ↑2 | ~ |
Allow the activation of the alternative N disposal pathway | ~ | ~ | ↑ | ~ |
Decrease body protein mass | ↔ | X2 | X2 | ~ |
Specific early development and pregnancy-related estrogen molecular species and functions not included.
Shows a coincidence of effect/function for different estrogen types in the same row.
↑: Exerts the effect described; ↓: Exerts an effect opposite to that described; ↔: Variable/not univocal responses; X: Does not exert the effect described; ~: Absent or insufficient information available; E1: Estrone; AE1: Acyl-estrone; E2: 17β-estradiol; AE2: Acyl-E2; ERs: Estrogen receptors; AF1: Activation function site 1 of the estrogen receptors; AF2: Activation function site 2 of the estrogen receptors; WAT: White adipose tissue.